Trading Ideas
GlaxoSmithKline, Vir Biotech Team Up in Hunt For Coronavirus Treatment
British drugmaker GlaxoSmithKline (GSK) and Vir Biotechnology Inc (VIR) on Monday announced a partnership to develop potential antibody treatments for COVID-19, the disease caused by the coronavirus.As part of the collaboration agreement GSK will make an investment in Vir of $250 million, priced at $37.73, representing a 10% premium to the closing share price on March 27, 2020, according to the announcement. Vir’s shares soared as much as 34% rising to around $39 in early U.S. trading following the news of GSK’s investment.Wall Street analysts take a cautious stance on Vir’s stock. The Hold analyst consensus rating is based on …read more […]
This Penny Stock Joins the Fight Against Coronavirus; Analyst Sees Triple-Digit Upside
With a market cap of a miniscule $10.16 million, you can firmly place biotech Capricor Therapeutics (CAPR) in the nano cap section. Although, according to one analyst, if recent developments are anything to go by, the Beverly Hills, California based company won’t be in the small fry category for much longer.H.C. Wainwright’s Joseph Pantginis reiterated a Buy on Capricor along with a $9.00 price target. The implication for investors? Potential upside of a humungous 737%. (To watch Pantginis’s track record, click here)So, what is driving an analyst to set such an extravagant target for such a tiny player? Well, among …read more […]
'This is blood money': Amazon warehouse workers stage second walkout over coronavirus fears
On Monday, workers at an Amazon warehouse in Staten Island walked off the job for a second time, just one week after holding an initial strike, citing continued coronavirus fears amid 26 cases of the virus at the warehouse. …read more […]
Zoom competitor 8×8 sees spike in usage amid coronavirus
8×8 CEO Vik Verma joins Yahoo Finance’s Seana Smith to discuss the company’s increase in usage amid the COVID-19 pandemic, as Zoom encounters concerns over its security and privacy. …read more […]
Options Volume Runs High on Controversial Coffee Chain
Overall options volume is pacing in the 99th annual percentile today …read more […]
Coronavirus Fighter Gilead Sciences Might Be Expensive, but It’s Still Worth Owning
Gilead Sciences (GILD) has positioned itself at the front line in the global war against COVID-19. The biotech’s experimental drug remdesivir is currently in two Gilead sponsored Phase 3 trials in over 90 locations, and two further investigator sponsored Phase 3 trials in China. The drug is currently registered in 11 ongoing trials, from which a handful of data readouts are expected in the next 2 to 6 weeks.So far, remdesivir has shown powerful in vitro efficacy against RNA viruses in cell-based assays and evidence of efficacy in both in California and Washington states; Additionally, there has also been some …read more […]
Coronavirus update: New York possibly near apex, markets open the week higher
Seemingly hopeful news came out of New York Monday, which could be nearing its apex of the novel coronavirus crisis, while markets opened higher to start a week that could see other metro areas surge in cases and deaths. …read more […]
Recent rally could be a 'bear market trap:' Miller Tabak strategist
The recent rallies in the markets could be a ‘bear-market trap’ says chief market strategist from Miller Tabak. …read more […]
Peloton halts live classes as employee tests positive for COVID-19
Peloton, whose flagship product is a stationary exercise bike priced at over $2,200, had said on Friday an employee at its New York City-based production studio has tested positive for COVID-19, according to a report https://www.theverge.com/2020/4/3/21207751/peloton-live-classes-employee-tested-positive-covid-19 by The Verge. Peloton said https://blog.onepeloton.com/peloton-covid-19-initiatives on Monday it would continue to add new, pre-recorded content on its Peloton App, which has a monthly subscription cost of $12.99. …read more […]
Federal Reserve to backstop Payment Protection Program loans
The Federal Reserve will backstop the Small Business Administration’s emergency loan program, as lenders continue to work through the Payment Protection Program. …read more […]
Use This Bear Market to Collect Free Money
Every wealth builder should be focused on maximizing their total return, which means minimizing their taxes.
Today, Alexander Green explains how the recent bear market created an important opportunity for investors to do exactly that.
Editor’s Note: Concerned about making smart investment moves in the midst of the coronavirus? Alexander Green is here for you. Make sure you read today’s article about minimizing your taxes with capital losses and check out his latest video update.
– Christina Grieves, Senior Managing Editor
In a headline like the one above, the words free money are usually in quotation marks, indicating the phrase is metaphorical, not literal.
There …read more […]
Coronavirus pandemic has driven a very 'ample' market correction: former European Central Bank chief
Yahoo Finance talks with former ECB president Jean-Claude Trichet about the path forward for the global economy amidst the coronavirus outbreak. …read more […]
OPEC Can’t Kill U.S. Shale
Saudi Arabia’s effort to crush US shale producers through ultra-low oil prices can only work if prices remain low, but once prices bounce back above $50, so will US shale production …read more […]
Warren Buffet’s Berkshire Hathaway sells off airline stocks, airline industry hit hard by virus
Warren Buffet’s company Berkshire Hathaway sold off millions of dollars in shares from airline companies Delta Air Lines and Southwest Airlines, after the coronavirus pandemic slammed the airline industry. Yahoo Finance’s On The Move panel breaks down the latest. …read more […]
